Rchr
J-GLOBAL ID：201401049906022939
Update date: Oct. 21, 2021
Kono Masayuki
Kono Masayuki
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
Kyoto University
About Kyoto University
Search "Kyoto University"
Papers (32)：
Osamu Kikuchi, Shinya Ohashi, Tomohisa Horibe, Masayuki Kohno, Yukie Nakai, Shin'ichi Miyamoto, Tsutomu Chiba, Manabu Muto, Koji Kawakami. Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma. SCIENTIFIC REPORTS. 2016. 6. 22452
Arong Gaowa, Tomohisa Horibe, Masayuki Kohno, Hiroshi Harada, Masahiro Hiraoka, Koji Kawakami. Potent anti-tumor effects of EGFR-targeted hybrid peptide on mice bearing liver metastases. CLINICAL & EXPERIMENTAL METASTASIS. 2016. 33. 1. 87-95
Arong Gaowa, Tomohisa Horibe, Masayuki Kohno, Yasuhiko Tabata, Hiroshi Harada, Masahiro Hiraoka, Koji Kawakami. Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2015. 92. 228-236
Masayuki Kohno, Tomohisa Horibe, Koji Ohara, Shinji Ito, Koji Kawakami. The Membrane-Lytic Peptides K8L9 and Melittin Enter Cancer Cells via Receptor Endocytosis following Subcytotoxic Exposure. CHEMISTRY & BIOLOGY. 2014. 21. 11. 1522-1532
Tomohisa Horibe, Aya Torisawa, Masayuki Kohno, Koji Kawakami. Synergetic cytotoxic activity toward breast cancer cells enhanced by the combination of Antp-TPR hybrid peptide targeting Hsp90 and Hsp70-targeted peptide. BMC CANCER. 2014. 14. 615
ｍore...
Patents (2)：
「EGFRを標的にした新規抗癌キメラペプチド」
「Hsp90を標的にした新規抗癌キメラペプチド」
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
